CRISPR Therapeutics
CRSP
$53.73
Share price
-3.45%
Change (1 day)
8.70%
Change (1 year)
CRISPR Therapeutics (CRSP) - Net assets
Net assets on the balance sheet as of December 2023 : $1.88 B
According to CRISPR Therapeutics's latest financial reports the company has $1.88 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
CRISPR Therapeutics - Net assets on balance sheet (from 2015 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $1.88 B | 0.39% |
| 2022-12-31 | $1.87 B | -21.84% |
| 2021-12-31 | $2.39 B | 44.18% |
| 2020-12-31 | $1.66 B | 77.15% |
| 2019-12-31 | $0.93 B | 139.53% |
| 2018-12-31 | $0.39 B | 108.8% |
| 2017-12-31 | $0.18 B | -19.33% |
| 2016-12-31 | $0.23 B | -899.5% |
| 2015-12-31 | $-29.13 M | 317.61% |
| 2014-12-31 | $-6.98 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | -88.10% | 🇺🇸 USA |